PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
21-Apr-2024 Agenda Announced for Semantic Data 2024: Taxonomy, Ontology, and Knowledge Graphs conference in London Henry Stewart Events
18-Apr-2024 Beckman Coulter Life Sciences Launches QbD1200+ Total Organic Carbon Analyzer Beckman Coulter Life Sciences
18-Apr-2024 Healthcare providers must involve engineers in pursuit of Net Zero ambitions or risk missing targets – IMechE report The Institution of Mechanical Engineers
15-Apr-2024 Bosch and Randox join forces in 150 million euro deal to target rapid, life-saving sepsis test Bosch and Randox
15-Apr-2024 Treatment combining prazosin and cyproheptadine shown to halve alcohol consumption amongst heavy drinkers in three months Kinnov Therapeutics
11-Apr-2024 Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to Integrate Devices into Pharma Portfolios Qinecsa
11-Apr-2024 Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions Qinecsa
11-Apr-2024 AbbVie’s AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults AbbVie
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead Sciences, Inc
09-Apr-2024 Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD Lundbeck
09-Apr-2024 Bios Health Group Unveils Bios Innovation Circle™ Bios Health Group
09-Apr-2024 KITE TO PRESENT COMPARISON OF OUTCOMES OF TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) FROM THE PIVOTAL ZUMA-2 TRIAL VERSUS THE EBMT REGISTRY OF ALLOSCT PATIENTS IN MANTLE CELL LYMPHOMA (MCL) AT 50TH EBMT 2024 KITE
09-Apr-2024 OncoZenge Appoints Åsa Nilsson as Clinical Research Manager OncoZenge
09-Apr-2024 Andaman7 Launches AI Supercharged Personal Health Record v5 Andaman7
09-Apr-2024 Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed CluePoints
08-Apr-2024 Vivet Therapeutics Doses First Patient in Cohort 2 in Phase 1/2 GATEWAY Clinical Trial for Treatment of Wilson Disease Vivet Therapeutics
05-Apr-2024 FDA Accepts Supplemental Biologics License Applications for BIMZELX® (bimekizumab-bkzx) for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations UCB
05-Apr-2024 Chiesi’s carbon minimal inhalers reach innovation milestone as phase III trials now underway Chiesi Group
05-Apr-2024 PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab PolTREG
03-Apr-2024 Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence Agilent Technologies